<?xml version="1.0" encoding="UTF-8"?>
<p>Quantitative proteomics can determine relative changes in protein content. Based on this technology, differences in protein abundance between healthy individuals and patients with cancer can be defined to identify disease markers. Proteomics has been widely used in human disease research [
 <xref rid="B21" ref-type="bibr">21</xref>]. The postlabeling analysis of proteins using the iTRAQ8-plex technology, combined with Data Dependent Acquisition (DADA), is currently the standard labeling method used in quantitative proteomics [
 <xref rid="B18" ref-type="bibr">18</xref>, 
 <xref rid="B22" ref-type="bibr">22</xref>, 
 <xref rid="B23" ref-type="bibr">23</xref>]. The iTRAQ8-plex technology is also a commonly used quantitative method, which can be applied to quantitative analysis in proteomics research [
 <xref rid="B24" ref-type="bibr">24</xref>, 
 <xref rid="B25" ref-type="bibr">25</xref>].
</p>
